Petros Pharmaceuticals Inc (NASDAQ:PTPI) traded at $0.48 at last check on current trade day and made an upward move of 18.23% on its previous day’s price.
Looking at the stock we see that its previous close was $0.41 and the beta (5Y monthly) reads 2.283 with the day’s price range being $0.4409 – $0.65. In terms of its 52-week price range, PTPI has a high of $2.27 and a low of $0.22. The company’s stock has gained about 43.50% over that past 30 days.
Petros Pharmaceuticals Inc has a market cap of $4.81 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the PTPI stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 32.91% off its SMA20 and 45.51% from its 50-day simple moving average. The RSI (14) is pointing at 62.27 while the volatility over the past week is 21.30% and jumps to 21.38% over the past one month. The beta value is 1.94, while the average true range (ATR) is currently pointing at 0.08.
Coming back to Petros Pharmaceuticals Inc (NASDAQ:PTPI), we note that the average 3-month trading volume was 1.69 million, while that of the preceding 10-day period stands at 0.97 million. Current shares outstanding are 10.01 million.
The insiders hold 8.87% of the company’s shares while institutions hold 1.81%. The data shows that short shares as of 2024-10-31, stood at 0.2 million at a short ratio of 0.72. This represents a 219.00 short interest in shares outstanding on 2024-10-31. Shares short fall in October from the previous month at 0.29 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 21.86% up in year-to-date price movement.
